在皮肤冠状动脉干预后预测对比诱导脏病的Sirtuin-1的诊断价值
Melis Ardic1, Cuma Bulent Gul2
1Department of Nephrology, Bursa Yuksek Ihtisas Training and Research Hospital, 16350 Bursa, Turkey.
Journal of clinical medicine
|June 13, 2025
概括
血清SIRT1水平可能不是对比引起的急性损伤 (CI-AKI) 的可靠静态标志物. 然而,在72小时内SIRT1的变化显示出作为CI-AKI早期检测的动态生物标志物的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 生物化学 生化学
背景情况:
- 对比诱导的急性损伤 (CI-AKI) 是心脏导管术后的一种严重并发症.
- 赛尔图因-1 (SIRT1) 是一种依赖NAD+的脱乙酶,与脏保护有关.
- 需要用于CI-AKI的早期诊断生物标志物.
研究的目的:
- 调查血清SIRT1水平作为CI-AKI的早期诊断生物标志物.
- 评估通过皮肤冠状动脉干预 (PCI) 后SIRT1水平和CI-AKI发展之间的相关性.
主要方法:
- 对50名接受选择性PCI的患者进行前性病例控制研究.
- 在PCI后的基线,24小时和72小时内测量的血清SIRT1水平.
- CI-AKI定义为血清肌素升高;患者分为CI-AKI和非CI-AKI组.
主要成果:
- 在任何时间点,两组之间静态血清SIRT1水平没有显著差异.
- 观察到SIRT1水平 (Δ0-72小时) 在72小时变化中的显著差异 (p = 0.037),CI-AKI组的下降更大.
- 发现了72小时SIRT1水平与CI-AKI之间的反向关联趋势 (p = 0.099).
结论:
- 血清SIRT1可能不能作为CI-AKI的静态诊断生物标志物.
- 对SIRT1的连续测量表明,它有可能成为早期CI-AKI检测的动态生物标志物.
- 需要进一步的试验来验证CI-AKI中的临床应用的串行SIRT1测量.
关键词:
CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI-AKI CI锡尔图因-1 蛋白质在PCI之后的PCI后.翻新主义 (renalism) 是一种翻新主义.更多相关视频
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69